glp-1 and neuroinflammation Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative disease treatment The protective role of GLP-1

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators

GLP-1 (Glucagon-like peptide-1) is an incretin secreted from intestinal L cells

Additionally, its thought to offer weight loss benefits

GLP-1 weight loss Chicago women benefit because these medications address the biological changes that occur with age

The loss of compounded GLP-1s is challenging, but its an opportunity for providers to step in and advocate for their patients and refer appropriately when the Bariatric Center is the best option, says Dr